NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP)

Translated title of the contribution: Desmopressin (DDAVP): A new solution to the treatment of enuresis

G. Segni, E. Salvaggio, D. Parenti, L. Cataldi, C. Auriti, A. Rossodivita, M. Fano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The therapeutic effectiveness of desmopressin (DDAVP) was evaluated in 40 children. The protocol consisted of 20 and 30 mcg administrations in a pattern including observation, placebo, and treatment for 6 weeks. There was a prompt response to treatment, and success was achieved in nearly 90% of cases. This, coupled with the tolerability of DDAVP and the complete absence of side-effects, indicates that it is both effective and safe for the management of enuresis.

Original languageItalian
Pages (from-to)45-52
Number of pages8
JournalMinerva Pediatrica
Volume34
Issue number1-2
Publication statusPublished - 1982

Fingerprint

Enuresis
Deamino Arginine Vasopressin
Therapeutics
Placebos
Observation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Segni, G., Salvaggio, E., Parenti, D., Cataldi, L., Auriti, C., Rossodivita, A., & Fano, M. (1982). NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP). Minerva Pediatrica, 34(1-2), 45-52.

NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP). / Segni, G.; Salvaggio, E.; Parenti, D.; Cataldi, L.; Auriti, C.; Rossodivita, A.; Fano, M.

In: Minerva Pediatrica, Vol. 34, No. 1-2, 1982, p. 45-52.

Research output: Contribution to journalArticle

Segni, G, Salvaggio, E, Parenti, D, Cataldi, L, Auriti, C, Rossodivita, A & Fano, M 1982, 'NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP)', Minerva Pediatrica, vol. 34, no. 1-2, pp. 45-52.
Segni G, Salvaggio E, Parenti D, Cataldi L, Auriti C, Rossodivita A et al. NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP). Minerva Pediatrica. 1982;34(1-2):45-52.
Segni, G. ; Salvaggio, E. ; Parenti, D. ; Cataldi, L. ; Auriti, C. ; Rossodivita, A. ; Fano, M. / NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP). In: Minerva Pediatrica. 1982 ; Vol. 34, No. 1-2. pp. 45-52.
@article{27d973ae70324f78be1d1f97f53ce8b3,
title = "NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP)",
abstract = "The therapeutic effectiveness of desmopressin (DDAVP) was evaluated in 40 children. The protocol consisted of 20 and 30 mcg administrations in a pattern including observation, placebo, and treatment for 6 weeks. There was a prompt response to treatment, and success was achieved in nearly 90{\%} of cases. This, coupled with the tolerability of DDAVP and the complete absence of side-effects, indicates that it is both effective and safe for the management of enuresis.",
author = "G. Segni and E. Salvaggio and D. Parenti and L. Cataldi and C. Auriti and A. Rossodivita and M. Fano",
year = "1982",
language = "Italian",
volume = "34",
pages = "45--52",
journal = "Minerva Pediatrica",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1-2",

}

TY - JOUR

T1 - NUOVA PROSPETTIVA TERAPEUTICA NELL'ENURESI LA DESMOPRESSINA (DDAVP)

AU - Segni, G.

AU - Salvaggio, E.

AU - Parenti, D.

AU - Cataldi, L.

AU - Auriti, C.

AU - Rossodivita, A.

AU - Fano, M.

PY - 1982

Y1 - 1982

N2 - The therapeutic effectiveness of desmopressin (DDAVP) was evaluated in 40 children. The protocol consisted of 20 and 30 mcg administrations in a pattern including observation, placebo, and treatment for 6 weeks. There was a prompt response to treatment, and success was achieved in nearly 90% of cases. This, coupled with the tolerability of DDAVP and the complete absence of side-effects, indicates that it is both effective and safe for the management of enuresis.

AB - The therapeutic effectiveness of desmopressin (DDAVP) was evaluated in 40 children. The protocol consisted of 20 and 30 mcg administrations in a pattern including observation, placebo, and treatment for 6 weeks. There was a prompt response to treatment, and success was achieved in nearly 90% of cases. This, coupled with the tolerability of DDAVP and the complete absence of side-effects, indicates that it is both effective and safe for the management of enuresis.

UR - http://www.scopus.com/inward/record.url?scp=0020061727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020061727&partnerID=8YFLogxK

M3 - Articolo

VL - 34

SP - 45

EP - 52

JO - Minerva Pediatrica

JF - Minerva Pediatrica

SN - 0026-4946

IS - 1-2

ER -